Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Bavari

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Antimicrobial Agents and Chemotherapy|February 13, 2001
Human antibodies to bacterial superantigens and their ability to inhibit T-cell activation and lethalityR D LeClaire, S Bavari
Infection and Immunity|February 1, 1995
Staphylococcal enterotoxin A and toxic shock syndrome toxin compete with CD4 for human major histocompatibility complex class II bindingS Bavari, R G Ulrich
The Journal of Infectious Diseases|August 1, 1996
Superantigen vaccines: a comparative study of genetically attenuated receptor-binding mutants of staphylococcal enterotoxin AS Bavari, B Dyas, R G Ulrich
Clinical Immunology and Immunopathology|September 1, 1995
Divergence of human and nonhuman primate lymphocyte responses to bacterial superantigensS Bavari, R E Hunt, R G Ulrich
Nature Structural Biology|July 1, 1995
Staphylococcal enterotoxins A and B share a common structural motif for binding class II major histocompatibility complex moleculesR G Ulrich, S Bavari, M A Olson
Vaccine|October 31, 1998
Development of engineered vaccines effective against structurally related bacterial superantigensR G Ulrich, M A Olson, S Bavari
Trends in Microbiology|December 1, 1995
Bacterial superantigens in human disease: structure, function and diversityR G Ulrich, S Bavari, M A Olson
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|April 1, 1989
Inhibition of human serum complement activity by diisopropylfluorophosphate and selected anticholinesterase insecticidesG P Casale, S Bavari, J J Connolly
The Journal of Infectious Diseases|September 9, 1999
Cross-reactive antibodies prevent the lethal effects of Staphylococcus aureus superantigensS Bavari, R G Ulrich, R D LeClaire
Infection and Immunity|December 1, 1993
Toxicity of staphylococcal enterotoxins potentiated by lipopolysaccharide: major histocompatibility complex class II molecule dependency and cytokine releaseB G Stiles, S Bavari, T Krakauer, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Antimicrobial Agents and Chemotherapy|February 13, 2001
Human antibodies to bacterial superantigens and their ability to inhibit T-cell activation and lethalityR D LeClaire, S Bavari
Infection and Immunity|February 1, 1995
Staphylococcal enterotoxin A and toxic shock syndrome toxin compete with CD4 for human major histocompatibility complex class II bindingS Bavari, R G Ulrich
The Journal of Infectious Diseases|August 1, 1996
Superantigen vaccines: a comparative study of genetically attenuated receptor-binding mutants of staphylococcal enterotoxin AS Bavari, B Dyas, R G Ulrich
Clinical Immunology and Immunopathology|September 1, 1995
Divergence of human and nonhuman primate lymphocyte responses to bacterial superantigensS Bavari, R E Hunt, R G Ulrich
Nature Structural Biology|July 1, 1995
Staphylococcal enterotoxins A and B share a common structural motif for binding class II major histocompatibility complex moleculesR G Ulrich, S Bavari, M A Olson
Vaccine|October 31, 1998
Development of engineered vaccines effective against structurally related bacterial superantigensR G Ulrich, M A Olson, S Bavari
Trends in Microbiology|December 1, 1995
Bacterial superantigens in human disease: structure, function and diversityR G Ulrich, S Bavari, M A Olson
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|April 1, 1989
Inhibition of human serum complement activity by diisopropylfluorophosphate and selected anticholinesterase insecticidesG P Casale, S Bavari, J J Connolly
The Journal of Infectious Diseases|September 9, 1999
Cross-reactive antibodies prevent the lethal effects of Staphylococcus aureus superantigensS Bavari, R G Ulrich, R D LeClaire
Infection and Immunity|December 1, 1993
Toxicity of staphylococcal enterotoxins potentiated by lipopolysaccharide: major histocompatibility complex class II molecule dependency and cytokine releaseB G Stiles, S Bavari, T Krakauer, et al.
Pageof 3